Oncology Network Aggregators: Gaining Popularity?

Article

Oncology Network Aggregators: Gaining Popularity?

August 16, 2023
Authors
Topics

Welcome to the August 2023 edition of our Monthly Insight Series. This month we take a deeper look into independent community oncology practices’ evolving interest in joining oncology network aggregators.

Handshake with digital global world map, network link connection and graph chart of stocks.

In our research for our annual Community Oncology Trend Report, we survey independent community oncology practices’ perceived likelihood of joining an oncology network aggregator (eg, the US Oncology Network, OneOncology, American Oncology Network) in the next 5 years. 

Survey data collected from 2021 to 2023 show that, year-over-year, independent practices rated increasingly higher likelihoods of joining a network aggregator, and the percentage of practices indicating a high likelihood of joining a network aggregator rose from 18% in 2021 to 35% in 2023 (Figure 1). 
 

Bar graph image.

An increasingly consolidated provider market, competitive and economic advantages touted by network aggregators, and mixed perspectives on these promised benefits color the story behind whether practices want to join these network aggregators. 

  • Provider consolidation fuels interest: The overall share of oncologists in community-based practices is declining as integrated delivery networks (IDNs) expand and independent practices struggle to remain competitive. In 2023, more than half of surveyed community practices name IDNs as their major competitor for oncology patients. As IDNs continue to acquire nearby practices and control more of the referral stream, community practices face more competition for new patients and threats to their patient volume. Oncologists looking for an alternative to joining an IDN will consider selling to or partnering with oncology network aggregators instead.
  • Network aggregators make big promises: Increasing administrative costs and decreasing provider reimbursement policies have led to challenging financial outlooks for community practices. Network aggregators claim to offer practices a variety of attractive services, including access to management services, enhanced infrastructure, and clinical tools, that help practices provide better cancer care, remain competitive in an increasingly complex market, and experience better profit margins.  
  • Qualitative feedback is mixed: While some practices believe network aggregators will provide them value, others remain skeptical of their impact. The potential for unfulfilled promises and loss of physician autonomy makes some practices wary of joining. When one community physician was asked if their practice had considered joining a network aggregator, they reflected that “[The network aggregators] make a lot of promises but can’t fulfill them . . . They just want to take over the practice, manage the practice, and make the doctors basically employees.” Smaller practices interested in joining also worry that they may not have the qualities that network aggregators look for in practices, decreasing their potential of joining one.

For more valuable insights, read our recently released 2023 Community Oncology Annual Trend Report. For further insights and musings on the oncology sector, check out our latest articles at https://www.hmpmarketaccessinsights.com/insights

As always, please feel free to reach out with any questions or comments you may have.
 

The Latest

Meet Dan: Researcher, Dad, and Oncology Report Innovator
Article
Meet Dan: Researcher, Dad, and Oncology Report Innovator

At HMP Market Access Insights, we’re lucky to have a team of experts dedicated to uncovering meaningful insights in the oncology space. One of those experts is Dan, whose work is shaping how we approach community oncology research.

Daniel Buchenberger
Leveraging the IDN Dataset: Your Essential Tool for 2025
Article
Leveraging the IDN Dataset: Your Essential Tool for 2025

As IDNs face increasing complexity in oncology management, having a strategic approach backed by actionable insights is critical. Our dataset doesn’t just offer data—it equips your teams with the tools to anticipate challenges and seize opportunities.

Emma Bijesse
Meet Ashutosh Sheth
Article
Meet Ashu: Organizer & Researcher Extraordinaire; Artist at Heart

Ashu is the glue that keeps our team organized and running smoothly. This year, he’s been particularly fascinated by the growing consolidation among community practices and how it’s reshaping the oncology landscape.

Ashutosh Sheth